These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 17520197)

  • 41. [Pathologic characteristics and evaluation of the pancreatic cancer].
    Fukushima N; Mukai K
    Gan To Kagaku Ryoho; 2005 May; 32(5):599-604. PubMed ID: 15918557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
    Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
    Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
    Kojima K; Vickers SM; Adsay NV; Jhala NC; Kim HG; Schoeb TR; Grizzle WE; Klug CA
    Cancer Res; 2007 Sep; 67(17):8121-30. PubMed ID: 17804724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cripto-1 overexpression is involved in the tumorigenesis of gastric-type and pancreatobiliary-type intraductal papillary mucinous neoplasms of the pancreas.
    Hong SP; Lee EK; Park JY; Jeon TJ; Bang S; Park S; Chung JB; Lee WJ; Kim H; Song SY
    Oncol Rep; 2009 Jan; 21(1):19-24. PubMed ID: 19082438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas.
    Izeradjene K; Combs C; Best M; Gopinathan A; Wagner A; Grady WM; Deng CX; Hruban RH; Adsay NV; Tuveson DA; Hingorani SR
    Cancer Cell; 2007 Mar; 11(3):229-43. PubMed ID: 17349581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new approach to managing intraductal papillary mucinous pancreatic neoplasms.
    Ghaneh P; Neoptolemos J
    Gut; 2007 Aug; 56(8):1041-4. PubMed ID: 17625140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunohistochemical expression of 14-3-3 sigma protein in intraductal papillary-mucinous tumor and invasive ductal carcinoma of the pancreas.
    Okada T; Masuda N; Fukai Y; Shimura T; Nishida Y; Hosouchi Y; Kashiwabara K; Nakajima T; Kuwano H
    Anticancer Res; 2006; 26(4B):3105-10. PubMed ID: 16886641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intraductal papillary mucinous neoplasms of the pancreas: clinical and pathological features and diagnostic approach.
    Katabi N; Klimstra DS
    J Clin Pathol; 2008 Dec; 61(12):1303-13. PubMed ID: 18703569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia.
    Körner M; Hayes GM; Rehmann R; Zimmermann A; Friess H; Miller LJ; Reubi JC
    Am J Pathol; 2005 Oct; 167(4):959-68. PubMed ID: 16192632
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular pathogenesis of intraductal papillary mucinous neoplasms of the pancreas.
    Thosani N; Dasari CS; Bhutani MS; Raimondo M; Guha S
    Pancreas; 2010 Nov; 39(8):1129-33. PubMed ID: 20881900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synchronous extrapancreatic malignant papillary mucinous neoplasms in a patient with intraductal papillary mucinous neoplasm of the pancreas: a rare case of simultaneous pancreatic, hepatic, and pulmonary involvement.
    Tarantino I; Mocciaro F; Barresi L; Vitulo P; Liotta R; Curcio G; Granata A; Pisa MD; Traina M
    Pancreas; 2012 Apr; 41(3):501-2. PubMed ID: 22415674
    [No Abstract]   [Full Text] [Related]  

  • 52. Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas.
    Yoshizawa K; Nagai H; Sakurai S; Hironaka M; Morinaga S; Saitoh K; Fukayama M
    Virchows Arch; 2002 Nov; 441(5):437-43. PubMed ID: 12447672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas.
    Sato N; Rosty C; Jansen M; Fukushima N; Ueki T; Yeo CJ; Cameron JL; Iacobuzio-Donahue CA; Hruban RH; Goggins M
    Am J Pathol; 2001 Dec; 159(6):2017-22. PubMed ID: 11733352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Locus/chromosome aberrations in intraductal papillary mucinous neoplasms analyzed by fluorescence in situ hybridization.
    Miyabe K; Hori Y; Nakazawa T; Hayashi K; Naitoh I; Shimizu S; Kondo H; Nishi Y; Yoshida M; Umemura S; Kato A; Ohara H; Joh T; Inagaki H
    Am J Surg Pathol; 2015 Apr; 39(4):512-20. PubMed ID: 25517961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma.
    Biankin AV; Kench JG; Dijkman FP; Biankin SA; Henshall SM
    Pathology; 2003 Feb; 35(1):14-24. PubMed ID: 12701679
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemical study of genetic alterations in intraductal and invasive ductal tumors of the pancreas.
    Islam HK; Fujioka Y; Tomidokoro T; Sugiura H; Takahashi T; Kondo S; Katoh H
    Hepatogastroenterology; 2001; 48(39):879-83. PubMed ID: 11462947
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Intraductal papillary-mucinous neoplasm of the pancreas].
    Yamaguchi K; Watanabe M; Nakamura M; Konomi H; Tanaka M
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():52-9. PubMed ID: 16457221
    [No Abstract]   [Full Text] [Related]  

  • 58. Molecular mechanism of intraductal papillary mucinous neoplasm and intraductal papillary mucinous neoplasm-derived pancreatic ductal adenocarcinoma.
    Fukuda A
    J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):519-23. PubMed ID: 25900667
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Senescence in intraductal papillary mucinous neoplasm of the pancreas.
    Miyasaka Y; Nagai E; Ohuchida K; Fujita H; Nakata K; Hayashi A; Mizumoto K; Tsuneyoshi M; Tanaka M
    Hum Pathol; 2011 Dec; 42(12):2010-7. PubMed ID: 21733551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas.
    Sato N; Ueki T; Fukushima N; Iacobuzio-Donahue CA; Yeo CJ; Cameron JL; Hruban RH; Goggins M
    Gastroenterology; 2002 Jul; 123(1):365-72. PubMed ID: 12105864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.